Drugs for Gastrointestinal Diseases Practice Questions

Q: Which of the following is the best medical treatment for GERD?

Proton pump inhibitors (PPIs). ### Explanation **Correct Option: B. Proton pump inhibitors (PPIs)** **Why PPIs are the best treatment:** Proton Pump Inhibitors (e.g., Omeprazole, Pantoprazole) are the **gold standard** and most effective medical treatment for Gastroesophageal Reflux Disease (GERD). They work by irreversibly inhibiting the **H+/K+ ATPase pump** (the final common pathway of acid secretion) in the gastric parietal cells. Compared to other agents, PPIs provide superior symptomatic relief, achieve faster healing of erosive esophagitis, and maintain remission more effectively. **Analysis of Incorrect Options:** * **A. H2 blocking agents (e.g., Ranitidine):** These inhibit only the histamine-stimulated pathway of acid secretion. While useful for mild or intermittent symptoms, they are less potent than PPIs and are prone to **tachyphylaxis** (rapidly diminishing response), making them inferior for long-term GERD management. * **C. Sucralfate:** This is a mucosal protective agent that requires an acidic environment to form a paste-like complex. It does not reduce acid production and is generally ineffective as a monotherapy for GERD. * **D. Prokinetic agents (e.g., Metoclopramide, Itopride):** These increase Lower Esophageal Sphincter (LES) tone and gastric emptying. While they address the pathophysiology of reflux, their efficacy is low and they carry significant side effects (e.g., extrapyramidal symptoms), making them only adjunctive treatments. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** PPIs should be taken **30–60 minutes before the first meal** of the day for maximal efficacy (when the number of H+/K+ ATPase pumps is highest). * **DOC:** PPIs are the Drug of Choice for GERD, Peptic Ulcer Disease, and **Zollinger-Ellison Syndrome**. * **Long-term risks:** Chronic PPI use is associated with Vitamin B12 deficiency, hypomagnesemia, increased risk of *C. difficile* infections, and osteoporotic fractures.

Q: Antiemetic effect of metoclopramide is mainly due to its action as:

D2 antagonist. **Explanation:** **Metoclopramide** is a substituted benzamide used as a prokinetic and antiemetic. Its primary mechanism for the **antiemetic effect** is the blockade of **D2 receptors** in the Chemoreceptor Trigger Zone (CTZ) of the medulla. By antagonizing these receptors, it raises the threshold of the CTZ and prevents the activation of the vomiting center. **Analysis of Options:** * **B. D2 Antagonist (Correct):** This is the predominant mechanism for its central antiemetic action. It also acts peripherally to increase Lower Esophageal Sphincter (LES) tone and promote gastric emptying (prokinetic effect) by antagonizing D2 receptors which normally inhibit ACh release. * **A. 5HT3 Antagonist:** While metoclopramide has weak 5HT3 antagonistic properties, this only contributes to its antiemetic effect at very high doses (e.g., in chemotherapy-induced vomiting). It is not its *main* mechanism. * **C. M3 Antagonist:** Metoclopramide does not block M3 receptors; in fact, it indirectly enhances cholinergic activity to promote GI motility. * **D. 5HT4 Agonist:** Metoclopramide does act as a 5HT4 agonist, but this action is primarily responsible for its **prokinetic effect** (increasing intestinal motility) rather than its central antiemetic effect. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Due to D2 blockade in the nigrostriatal pathway, it can cause **Extrapyramidal Symptoms (EPS)** like acute dystonia and akathisia (especially in children). It also causes **hyperprolactinemia** (leading to gynecomastia/galactorrhea). * **Drug of Choice:** It is often used for gastroparesis (e.g., diabetic gastroparesis) and as an adjunct in gastrointestinal radiology. * **Contraindication:** It should never be used in cases of **mechanical GI obstruction** or pheochromocytoma.

Q: Which antiemetic phenothiazine with labyrinthine suppressant activity is used for vertigo?

Prochlorperazine. **Explanation:** **Prochlorperazine** (Option A) is the correct answer. It is a piperazine-side chain phenothiazine that acts primarily as a D2-receptor antagonist in the Chemoreceptor Trigger Zone (CTZ). Unlike many other phenothiazines, it possesses significant **labyrinthine suppressant** properties. It is specifically indicated for the control of vertigo associated with Meniere’s disease, labyrinthitis, and vestibular disorders, in addition to its use as a potent antiemetic. **Analysis of Incorrect Options:** * **B. Cinnarizine:** While this is a drug of choice for motion sickness and vertigo, it is an **antihistamine (H1 blocker)** with calcium channel blocking activity, not a phenothiazine. * **C. Hyoscine (Scopolamine):** This is an **anticholinergic** drug. It is the most effective agent for the *prophylaxis* of motion sickness but lacks the phenothiazine structure and is not primarily used for vestibular vertigo. * **D. Promethazine:** This is a phenothiazine, but it is classified primarily as a **sedative-antihistamine**. While it is used for motion sickness due to its anticholinergic and H1-blocking effects, Prochlorperazine is the specific phenothiazine preferred for its superior labyrinthine suppressant activity in clinical vertigo. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Motion Sickness:** Hyoscine (prophylactic). * **DOC for Vertigo (Acute attack):** Prochlorperazine or Cinnarizine. * **Side Effects:** As a D2 blocker, Prochlorperazine can cause **Extrapyramidal Symptoms (EPS)** like acute dystonia, especially in children and young adults. * **Mechanism in Vertigo:** It suppresses the vestibular apparatus by inhibiting the trigger impulses from the semicircular canals to the vomiting center.

Q: A patient is diagnosed with Zollinger-Ellison syndrome. Which of the following would be the most appropriate pharmacotherapy?

Omeprazole. **Zollinger-Ellison Syndrome (ZES)** is characterized by a gastrin-secreting tumor (gastrinoma), usually located in the pancreas or duodenum. This leads to massive hypersecretion of gastric acid, resulting in severe, recurrent peptic ulcers and diarrhea. **1. Why Omeprazole is correct:** Proton Pump Inhibitors (PPIs) like **Omeprazole** are the drugs of choice for ZES [1]. They irreversibly inhibit the $H^+/K^+$-ATPase pump in gastric parietal cells, which is the final common pathway of acid secretion [1]. Because PPIs can achieve near-total suppression of acid regardless of the stimulus (gastrin, histamine, or acetylcholine), they are effective even against the extreme hypergastrinemia seen in ZES [1]. High doses are typically required initially. **2. Why the other options are incorrect:** * **Famotidine:** This is an $H_2$ receptor antagonist. While it reduces acid, it is significantly less potent than PPIs and cannot adequately control the massive acid output triggered by gastrinomas. * **Fluorouracil (5-FU):** This is a cytotoxic antimetabolite used in cancer chemotherapy. While ZES involves a tumor, the primary management of symptoms and mucosal damage relies on acid suppression, not 5-FU. * **Erythropoietin:** This is a hormone that stimulates red blood cell production; it has no role in acid-peptic disease. **Clinical Pearls for NEET-PG:** * **Diagnosis:** ZES is suspected when fasting serum gastrin levels are >1000 pg/mL. The **Secretin Stimulation Test** is the most specific provocative test (Secretin causes a paradoxical *increase* in gastrin in ZES patients). * **MEN-1 Association:** Approximately 25% of ZES cases occur as part of Multiple Endocrine Menaplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Drug of Choice:** PPIs are the DOC for ZES, NSAID-induced ulcers, and H. pylori-associated peptic ulcer disease [1].

Q: All of the following are effective against cytotoxic drug-induced emesis except?

Hyoscine. **Explanation:** The management of chemotherapy-induced nausea and vomiting (CINV) targets specific neurotransmitter pathways in the **Chemoreceptor Trigger Zone (CTZ)** and the **Vagal afferents** in the GI tract. **Why Hyoscine is the correct answer:** Hyoscine (Scopolamine) is an anticholinergic drug that primarily acts on the vestibular system (M1 receptors). It is the drug of choice for **motion sickness** and vertigo but has **no significant efficacy** against cytotoxic drug-induced emesis. CINV is primarily mediated by serotonin (5-HT3), dopamine (D2), and substance P (NK1), rather than the vestibular-cholinergic pathway. **Analysis of other options:** * **Ondansetron:** A 5-HT3 receptor antagonist. It is the first-line agent for preventing acute CINV by blocking serotonin receptors on vagal afferents and the CTZ. * **Dexamethasone:** A corticosteroid that is highly effective against CINV, especially when used in combination with 5-HT3 antagonists. Its mechanism involves reducing peritumoral inflammation and prostaglandin synthesis. * **Metoclopramide:** A D2 receptor antagonist. In high doses, it also possesses 5-HT3 antagonistic activity, making it effective against cisplatin-induced emesis (though now largely superseded by newer agents). **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of choice for Motion Sickness:** Hyoscine (administered as a transdermal patch behind the ear). 2. **Drug of choice for CINV (Acute):** Ondansetron (5-HT3 antagonist). 3. **Drug of choice for Delayed CINV:** Aprepitant (NK1 receptor antagonist). 4. **Drug of choice for Morning Sickness (Pregnancy):** Doxylamine + Pyridoxine. 5. **Metoclopramide Side Effect:** Can cause Extrapyramidal Symptoms (EPS) like acute dystonia due to central D2 blockade.

Q: What is the antibiotic of choice in a cirrhotic patient to prevent hepatic encephalopathy?

Rifaximin. ### Explanation **Correct Answer: D. Rifaximin** **Mechanism and Rationale:** Hepatic encephalopathy (HE) is primarily caused by the accumulation of neurotoxic ammonia, produced by urea-splitting bacteria in the gut. **Rifaximin** is a semi-synthetic, non-absorbable derivative of Rifampin. It acts locally in the gastrointestinal tract to inhibit bacterial RNA synthesis, thereby reducing the population of ammonia-producing enteric flora. Because it has minimal systemic absorption (<0.4%), it offers a superior safety profile with fewer systemic side effects, making it the current **drug of choice** for the prevention of recurrent HE episodes. **Analysis of Incorrect Options:** * **A. Neomycin:** Historically used to decrease ammonia-producing bacteria. However, it is no longer the first choice due to risks of **ototoxicity and nephrotoxicity**, even with minimal absorption, especially in patients with renal impairment. * **B. Ampicillin:** While it can alter gut flora, it is not specific for HE and carries a high risk of developing antibiotic resistance and *Clostridioides difficile* infection. * **C. Metronidazole:** Effective against anaerobes that produce ammonia, but long-term use is limited by the significant risk of **peripheral neuropathy**. **NEET-PG High-Yield Pearls:** * **First-line treatment for acute HE:** Lactulose (a non-absorbable disaccharide that traps ammonia as ammonium ions [$NH_4^+$] by acidifying the colon). * **Rifaximin's Role:** Primarily used as an add-on therapy to Lactulose for the prevention of recurrence. * **Mechanism of Rifaximin:** Binds to the beta-subunit of bacterial DNA-dependent RNA polymerase. * **Clinical Advantage:** Unlike Neomycin, Rifaximin does not require dosage adjustment in renal failure and has a lower potential for drug-drug interactions.

Q: What is not a rationale for sucralfate therapy in peptic ulcers?

It has an acid neutralizing action.. **Explanation:** Sucralfate is a complex of **aluminum hydroxide and sulfated sucrose**. Its primary mechanism of action is physical rather than chemical, making it a "cytoprotective" agent rather than an antacid. **1. Why Option A is the correct answer:** Sucralfate **does not have a significant acid-neutralizing capacity**. Unlike antacids (like Magnesium or Aluminum hydroxide), sucralfate requires an **acidic environment (pH < 4)** to be activated. In acidic medium, it polymerizes into a sticky, viscous paste that binds selectively to the base of the ulcer crater. Therefore, claiming it neutralizes acid is pharmacologically incorrect. **2. Why the other options are incorrect (Mechanisms of Sucralfate):** * **Option B:** The negatively charged sucrose sulfate binds to positively charged proteins (albumin, fibrinogen) in the ulcer base, forming a physical barrier that **prevents degradation by pepsin** and bile salts. * **Option C:** Sucralfate binds to **Epidermal Growth Factor (EGF)** and fibroblast growth factor, concentrating them at the ulcer site to promote mucosal regeneration and healing. * **Option D:** It stimulates the local release of **Prostaglandins (PGE2 and PGI2)** and nitric oxide, which increases mucosal blood flow and bicarbonate secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Administration:** It must be taken on an **empty stomach** (1 hour before meals). * **Drug Interactions:** Since it requires low pH for activation, it should **not** be given simultaneously with **Antacids, H2 blockers, or PPIs** (maintain a gap of 30–60 mins). * **Side Effects:** The most common side effect is **constipation** (due to the aluminum content). * **Hypophosphatemia:** It can bind to dietary phosphates, potentially leading to low phosphate levels in chronic use.

Q: Which of the following statements regarding H2 receptor antagonists is FALSE?

They consistently lower the esophageal sphincter pressure.. **Explanation:** **Why Option C is the Correct (False) Statement:** H2 receptor antagonists (H2RAs) like Ranitidine and Famotidine primarily act on the parietal cells of the stomach. They have **no significant effect on the Lower Esophageal Sphincter (LES) pressure**. In clinical practice, drugs that decrease LES pressure (like Calcium Channel Blockers or Nitrates) can actually worsen Gastroesophageal Reflux Disease (GERD). Since H2RAs are used to treat GERD, they would be counterproductive if they lowered LES pressure. **Analysis of Other Options:** * **Option A:** H2RAs are competitive antagonists. They produce a **dose-dependent inhibition** of gastric acid secretion, especially effective against basal (nocturnal) acid secretion stimulated by histamine. * **Option B:** These drugs effectively reduce both the **total volume** of gastric juice and the **concentration of Hydrogen ions** (acidity). They also indirectly reduce pepsin secretion. * **Option D:** Intrinsic factor is secreted by the same parietal cells that secrete HCl. While H2RAs do reduce the secretion of intrinsic factor, this is rarely clinically significant in short-term use because the body has large stores of Vitamin B12. **NEET-PG High-Yield Pearls:** * **Cimetidine Specifics:** It is a potent **P450 enzyme inhibitor** and has **anti-androgenic effects** (can cause gynecomastia and galactorrhea). * **Drug of Choice:** Proton Pump Inhibitors (PPIs) have largely replaced H2RAs for PUD and GERD due to superior efficacy and longer duration of action. * **Tolerance:** Unlike PPIs, H2RAs can exhibit **tachyphylaxis** (rapidly diminishing response) within 3-7 days of starting therapy.

Question 1

Which of the following is the best medical treatment for GERD?

Accepted Answer

Proton pump inhibitors (PPIs)

Answer

H2 blocking agents

Answer

Sucralfate

Answer

Prokinetic agents

Question 2

Antiemetic effect of metoclopramide is mainly due to its action as:

Accepted Answer

D2 antagonist

Answer

5HT3 antagonist

Answer

M3 antagonist

Answer

5HT4 agonist

Question 3

Which antiemetic phenothiazine with labyrinthine suppressant activity is used for vertigo?

Accepted Answer

Prochlorperazine

Answer

Cinnarizine

Answer

Hyoscine

Answer

Promethazine

Question 4

Which of the following pharmacologic agents is not used in the management of Crohn's disease?

Accepted Answer

Ustekinumab

Answer

Infliximab

Answer

Adalimumab

Answer

Natalizumab

Question 5

Which of the following drugs is NOT used for paralytic ileus following bowel resection surgery?

Accepted Answer

Naloxone

Answer

Alvinopam

Answer

Dihydroergotamine

Answer

Methylnaltrexone

Question 6

A patient is diagnosed with Zollinger-Ellison syndrome. Which of the following would be the most appropriate pharmacotherapy?

Accepted Answer

Omeprazole

Answer

Erythropoietin

Answer

Famotidine

Answer

Fluorouracil

Question 7

All of the following are effective against cytotoxic drug-induced emesis except?

Accepted Answer

Hyoscine

Answer

Dexamethasone

Answer

Metoclopramide

Answer

Ondansetron

Question 8

What is the antibiotic of choice in a cirrhotic patient to prevent hepatic encephalopathy?

Accepted Answer

Rifaximin

Answer

Neomycin

Answer

Ampicillin

Answer

Metronidazole

Question 9

What is not a rationale for sucralfate therapy in peptic ulcers?

Accepted Answer

It has an acid neutralizing action.

Answer

It inhibits pepsin mediated protein hydrolysis.

Answer

It stimulates the production of epidermal growth factor.

Answer

It stimulates prostaglandin synthesis.

Question 10

Which of the following statements regarding H2 receptor antagonists is FALSE?

Accepted Answer

They consistently lower the esophageal sphincter pressure.

Answer

They produce a dose-dependent inhibition of gastric acid secretion elicited by histamine.

Answer

They reduce the volume as well as H+ ion concentration of gastric juice.

Answer

They also reduce the secretion of intrinsic factor.

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?